Invitrogen™ LPL Monoclonal Antibody (2C5)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA515503

Catalog No. PIMA515503

Description

MA5-15503 targets LPL in indirect ELISA, WB applications and shows reactivity with Human samples. The MA5-15503 immunogen is purified recombinant fragment of LPL expressed in E. Coli. MA5-15503 detects LPL which has a predicted molecular weight of approximately 53.1kDa.

LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.

Specifications

• Antigen: LPL
• Classification: Monoclonal
• Concentration: Conc. Not Determined
• Formulation: ascites with 0.03% sodium azide
• Gene Accession No.: P06858
• Gene Symbols: LPL
• Immunogen: Purified recombinant fragment of LPL expressed in E. Coli.
• Regulatory Status: RUO
• Gene ID (Entrez): 4023
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: ELISA, Western Blot
• Clone: 2C5
• Conjugate: Unconjugated
• Gene: LPL
• Gene Alias: adipose lipoprotein lipase; alpha lipase; HDLCQ11; I79_006077; LIPD; lipoprotein lipase; lipoprotein lipase (EC 3.1.1.34); lipoprotein lipase precursor; lipoprotein lipase preprotein; Lipoprotein lipase-like protein; LPL; O 1-4-5; phospholipase A1; triacylglycerol lipase
• Host Species: Mouse
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov